Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

AMETEK (AME) Q3 Earnings Beat Estimates, Revenues Up Y/Y

Published 10/30/2019, 10:20 PM
Updated 07/09/2023, 06:31 AM

AMETEK, Inc. (NYSE:AME) reported third-quarter 2019 adjusted earnings of $1.06 per share, which beat the Zacks Consensus Estimate by 5 cents and also surpassed management’s guidance of $1.00-$1.02. The figure improved 16.5% from the year-ago quarter and 0.9% sequentially.

Net sales improved 7% on a year-over-year basis but declined 0.9% sequentially to $1.28 billion. The figure fell short of the Zacks Consensus Estimate of $1.29 billion.

Robust organic growth and contributions from acquisitions drove year-over-year top-line improvement. Further, improved operational activities and strong segmental performance aided results.

We believe that the company’s proper execution of the four core growth strategies of operational excellence, global market expansion, investments in product development and acquisitions are expected to continue benefiting business growth in the near term as well as the long haul.

Top Line in Detail

AMETEK reports sales under two organized segments — Electronic Instruments Group (EIG) and Electromechanical Group (EMG).

EIG (63.9% of total sales): The company generated $815.6 million of sales from this segment, reflecting growth of 10% from the year-ago quarter. The benefits from acquisitions of Forza, Telular and Spectro Scientific drove year-over-year growth in this segment. Further, organic sales in the reported quarter remained positive in this segment.

EMG (36.1% of sales): This segment generated $461.1 million of sales in the first quarter, which improved 2.3% on a year-over-year basis. The segment’s top-line growth can primarily be attributed to solid organic sales growth and positive contributions from the Pacific Design Technologies buyout.

AMETEK, Inc. Price, Consensus and EPS Surprise

AMETEK, Inc. price-consensus-eps-surprise-chart | AMETEK, Inc. Quote

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Operating Details

For the third quarter, operating margin was 23.6%, which expanded 140 bps from the year-ago quarter figure.

Segment wise, operating margins for EIG and EMG were 26.9% and 22.4 %, expanding 130 bps and 180 bps, respectively, on a year-over-year basis.

Operating expenses were $975.6 million, up 5.2% year over year. However, the figure contracted 140 bps from the year-ago quarter as a percentage of net sales.

Balance Sheet

As of Sep 30, 2019, cash and cash equivalents were $735.4 million, up from $567.9 million as of Jun 30, 2019.

Long-term debt was $2.2 billion, down from $2.4 billion in the previous quarter.

Guidance

For fourth-quarter 2019, AMETEK expects sales to improve by a mid-single digit on a year-over-year basis. The Zacks Consensus Estimate for sales is pegged at $1.33 billion.

Earnings are anticipated to be $1.01-$1.03 per diluted share, reflecting year-over-year growth of 5-7%. The Zacks Consensus Estimate for earnings is projected at $1.03.

For 2019, the company anticipates total sales to improve in the range of mid to high-single digits from 2018. Further, organic sales growth is projected at 3%. AMETEK also anticipates benefiting from acquisition contributions. The Zacks Consensus Estimate is pegged at $5.20 billion.

Further, AMETEK revised guidance upward for adjusted earnings per share from $4.04-$4.10 to $4.12-$4.14, reflecting growth of 13% from 2018. The Zacks Consensus Estimate for 2019 earnings is pegged at $4.10.

Zacks Rank & Key Picks

AMETEK currently has a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader technology sector are NetEase, Inc. (NASDAQ:NTES) , Itron, Inc. (NASDAQ:ITRI) and Five9, Inc. (NASDAQ:FIVN) . All the stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth rate for NetEase, Itron and Five9 is currently pegged at 31.93%, 25% and 10%, respectively.

Free: Zacks’ Single Best Stock Set to Double

Today you are invited to download our just-released Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.

Download Free Report Now >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


NetEase, Inc. (NTES): Free Stock Analysis Report

Five9, Inc. (FIVN): Free Stock Analysis Report

Itron, Inc. (ITRI): Free Stock Analysis Report

AMETEK, Inc. (AME): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.